Evidence map›Paper›PMID 32933369›Full record

Observational studyImmunotherapy2020

Clinical impact of COVID-19 in a single-center cohort of a prospective study in cancer patients receiving immunotherapy.

Melissa Bersanelli, Teresa Zielli, Fabiana Perrone, Chiara Casartelli, Fabiana Pratticò, Elena Rapacchi, Roberta Camisa, Michele Tognetto, Alberto Clemente, Diana Giannarelli and 5 more

Open access · greenAbstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Immunotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Vaccines for preventing infections in adults with solid tumours.The Cochrane database of systematic reviews · 2025
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Melissa BersanelliMedical Oncology Unit, University of Parma, 43126, Parma, Italy.ORCID 0000-0002-6527-6281
Teresa ZielliMedical Oncology Unit, University of Parma, 43126, Parma, Italy.
Fabiana PerroneMedical Oncology Unit, University of Parma, 43126, Parma, Italy.ORCID 0000-0001-8090-770X
Chiara CasartelliMedical Oncology Unit, University of Parma, 43126, Parma, Italy.
Fabiana PratticòMedicine & Surgery Department, University of Parma, Parma, Italy.
Elena RapacchiMedical Oncology Unit, University of Parma, 43126, Parma, Italy.
Roberta CamisaMedical Oncology Unit, University of Parma, 43126, Parma, Italy.
Michele TognettoMedical Oncology Unit, University of Parma, 43126, Parma, Italy.
Alberto ClementeBiostatistics & Clinical Research Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014, Meldola, Italy.
Diana GiannarelliBiostatistical Unit, Regina Elena National Cancer Institute, IRCCS, 00144, Rome, Italy.
Sara Elena RebuzziMedical Oncology Unit, University of Parma, 43126, Parma, Italy.ORCID 0000-0003-0546-6304
Alessandro LeonettiMedical Oncology Unit, University of Parma, 43126, Parma, Italy.ORCID 0000-0001-5415-6703
Paola BordiMedical Oncology Unit, University of Parma, 43126, Parma, Italy.
Marcello TiseoMedicine & Surgery Department, University of Parma, Parma, Italy.
Sebastiano ButiMedical Oncology Unit, University of Parma, 43126, Parma, Italy.ORCID 0000-0003-0876-0226
University of Parma · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITIstituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ImmunotherapyAdultAgedAged, 80 and overAntineoplastic Agents, ImmunologicalBetacoronavirusCoronavirus InfectionsCOVID-19FemaleHumansIncidenceItalyLungMaleMiddle AgedNeoplasmsAntineoplastic Agents, Immunologicalanti-PD-1cancer patientsCOVID-19immune checkpoint inhibitorsimmunotherapyinfluenza vaccineinterstitial pneumoniaSARS-CoV2

Identifiers

PMID32933369
PMCPMC7493722
OpenAlexW3084708524

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.